Clinical Trial Update: AXS-05 Phase II Trial on Smoking Behavior [Phase 2]

View source ↗

Summary

Phase 2 trial update for AXS-05 in smoking cessation shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking Cessation

Drugs mentioned

• AXS-05 (dextromethorphan-quinidine)

Snippet

Sponsor: James Davis | Conditions: Smoking Cessation, Smoking, Cigarette | Phase 2 | Status: COMPLETED | Results posted: 2022-10-12